1st Quarter - Report
FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TEGAN GELFAND | — |
Taxation/Internal Revenue Code TAX
Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TEGAN GELFAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.